Germany Could Consider Banning Ozempic Drug Export, Der Spiegel Reports
15 Novembre 2023 - 3:50PM
Dow Jones News
--Germany could consider banning the export of Novo Nordisk's
Ozempic drug amid a shortage of the medication for diabetes
patients, the head of the country's federal institute for drugs and
medical devices tells Der Spiegel in an interview. Ozempic is
approved for diabetes treatment but is also being used "off-label"
as a weight-loss medication.
--The institute's president, Karl Broich, says that Ozempic is
cheaper in Germany than in some other countries and that some
supply is ending up in other European countries or the U.S., the
magazine reports.
--"We need the drug for the treatment of diabetes patients and
not as a life-style medication," he says, adding that if current
measures don't work, a ban could be considered, according to Der
Spiegel.
Full story in German: https://tinyurl.com/2bzrm5by
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
November 15, 2023 09:35 ET (14:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Novo Nordisk (NYSE:NVO)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Novo Nordisk (NYSE:NVO)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
